Is Corvus Pharmaceuticals Inc (NASDAQ: CRVS) Proving The Doubters Wrong?
Corvus Pharmaceuticals Inc (CRVS) concluded trading on Wednesday at a closing price of $4.70, with 14.06 million shares of worth about $66.1 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 146.07% during that period and on December 18, 2024 the price saw a […]
